Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership2,185,500 shares
Latest Disclosed Value $ 212,539,875
Goldman Sachs Group Inc ownership in RVMD / Revolution Medicines, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 2,185,500 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $212,539,875 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 2,491,274 shares of Revolution Medicines, Inc.. This represents a change in shares of -12.27% during the quarter.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (RVMD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:RVMD / Revolution Medicines, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES CMN 76155X100 2,185,500 -305,774 -12.27 212,540 7.11 0.0057
2026-02-10 2025-12-31 13F REVOLUTION MEDICINES CMN 76155X100 2,491,274 1,753,248 237.56 198,430 475.74 0.0245
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES CMN 76155X100 738,026 -1,415,371 -65.73 34,466 -56.50 0.0042
2025-08-14 2025-06-30 13F REVOLUTION MEDICINES CMN 76155X100 2,153,397 -11,104 -0.51 79,223 3.51 0.0108
2025-06-27 2025-03-31 13F/A-2 REVOLUTION MEDICINES CMN 76155X100 2,164,501 -465,651 -17.70 76,537 -33.47 0.0124
2025-05-16 2025-03-31 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 2,164,501 -465,651 76,537 0.0124
2025-05-09 2025-03-31 13F REVOLUTION MEDICINES CMN 76155X100 2,164,501 -465,651 76,537 0.0023
2025-02-11 2024-12-31 13F REVOLUTION MEDICINES CMN 76155X100 2,630,152 275,550 11.70 115,043 7.74 0.0181
2024-11-14 2024-09-30 13F REVOLUTION MEDICINES CMN 76155X100 2,354,602 906,507 62.60 106,781 90.00 0.0172
2024-08-13 2024-06-30 13F REVOLUTION MEDICINES CMN 76155X100 1,448,095 324,645 28.90 56,201 55.21 0.0095
2024-05-15 2024-03-31 13F REVOLUTION MEDICINES CMN 76155X100 1,123,450 70,193 6.66 36,209 19.87 0.0064
2024-05-14 2023-12-31 13F/A-2 REVOLUTION MEDICINES CMN 76155X100 1,053,257 425,812 67.86 30,207 73.93 0.0056
2024-03-01 2023-12-31 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 1,053,257 30,207
2024-02-13 2023-12-31 13F REVOLUTION MEDICINES CMN 76155X100 1,053,257 425,812 30,207 0.0054
2024-05-15 2023-09-30 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 627,445 -70,234 -10.07 17,368 -6.94 0.0037
2023-11-14 2023-09-30 13F REVOLUTION MEDICINES CMN 76155X100 627,445 -70,234 17,368 0.0035
2024-05-14 2023-06-30 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 697,679 -438,379 -38.59 18,663 -24.16 0.0040
2023-08-15 2023-06-30 13F REVOLUTION MEDICINES CMN 76155X100 697,679 -438,379 18,663 0.0038
2024-05-14 2023-03-31 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 1,136,058 134,841 13.47 24,607 3.18 0.0057
2023-05-11 2023-03-31 13F REVOLUTION MEDICINES CMN 76155X100 1,136,058 134,841 24,607 0.0053
2024-05-14 2022-12-31 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 1,001,217 -39,209 -3.77 23,849 119,140.00 0.0058
2023-02-13 2022-12-31 13F REVOLUTION MEDICINES CMN 76155X100 1,001,217 -39,209 23,849 0.0053
2024-05-14 2022-09-30 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 1,040,426 150,929 16.97 21 17.65 0.0052
2022-11-14 2022-09-30 13F REVOLUTION MEDICINES CMN 76155X100 1,040,426 150,929 20,517 0.0047
2024-05-14 2022-06-30 13F/A-2 REVOLUTION MEDICINES CMN 76155X100 889,497 19,990 2.30 17 -99.92 0.0043
2022-08-18 2022-06-30 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 889,497 19,990 17,336 0.0039
2022-08-15 2022-06-30 13F REVOLUTION MEDICINES CMN 76155X100 889,497 19,990 17,336 0.0039
2022-05-16 2022-03-31 13F REVOLUTION MEDICINES CMN 76155X100 869,507 175,304 25.25 22,181 26.94 0.0047
2022-02-17 2021-12-31 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 694,203 -279,695 -28.72 17,473 -34.78 0.0035
2022-02-14 2021-12-31 13F REVOLUTION MEDICINES CMN 76155X100 694,203 -279,695 17,473 0.0010
2022-01-20 2021-09-30 13F/A-1 REVOLUTION MEDICINES CMN 76155X100 973,898 269,641 38.29 26,792 19.86 0.0057
2021-11-10 2021-09-30 13F REVOLUTION MEDICINES CMN 76155X100 973,898 269,641 26,792 0.0017
2021-08-13 2021-06-30 13F REVOLUTION MEDICINES CMN 76155X100 704,257 -2,434 -0.34 22,353 -31.06 0.0050
2021-05-17 2021-03-31 13F REVOLUTION MEDICINES CMN 76155X100 706,691 199,625 39.37 32,423 61.52 0.0082
2021-02-12 2020-12-31 13F REVOLUTION MEDICINES CMN 76155X100 507,066 453,272 842.61 20,074 972.33 0.0052
2020-11-13 2020-09-30 13F REVOLUTION MEDICINES CMN 76155X100 53,794 -75,056 -58.25 1,872 -53.98 0.0005
2020-08-12 2020-06-30 13F REVOLUTION MEDICINES CMN 76155X100 128,850 63,162 96.15 4,068 182.70 0.0012
2020-05-15 2020-03-31 13F REVOLUTION MEDICINES CMN 76155X100 65,688 65,688 1,439 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-10 2025-12-31 13F REVOLUTION MEDICINES CMN Call 21,000 0.00 1,673 70.61 n/a n/a n/a
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES CMN Call 21,000 981 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F REVOLUTION MEDICINES CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-10 2025-12-31 13F REVOLUTION MEDICINES CMN Put 21,000 0.00 1,673 70.61 n/a n/a n/a
2025-11-14 2025-09-30 13F REVOLUTION MEDICINES CMN Put 21,000 981 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.